Zidovudine administered to women infected with human immunodeficiency virus type 1 and to their neonates reduces pediatric infection independent of an effect on levels of maternal virus
- 1 June 1997
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 130 (6) , 906-914
- https://doi.org/10.1016/s0022-3476(97)70276-2
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Obstetrical Factors and the Transmission of Human Immunodeficiency Virus Type 1 from Mother to ChildNew England Journal of Medicine, 1996
- Identification of Levels of Maternal HIV-1 RNA Associated With Risk of Perinatal TransmissionJAMA, 1996
- Maternal plasma human immunodeficiency virus type 1 RNA level: a determinant and projected threshold for mother-to-child transmission.Proceedings of the National Academy of Sciences, 1995
- Phytohemagglutinin-inducible p24 in peripheral blood mononuclear cells as a predictor of human immunodeficiency virus type 1 vertical transmission and infant clinical statusThe Pediatric Infectious Disease Journal, 1994
- Quantitation of human immunodeficiency virus type 1 during pregnancy: relationship of viral titer to mother-to-child transmission and stability of viral load.Proceedings of the National Academy of Sciences, 1994
- Immunological and Virological Clues for Mother-to-Child Transmission of HIV-1 and HIV-2Published by American Medical Association (AMA) ,1994
- Relation of the Course of HIV Infection in Children to the Severity of the Disease in Their Mothers at DeliveryNew England Journal of Medicine, 1994
- Cellular immune factors associated with mother-to-infant transmission of HIVAIDS, 1993
- Risk for perinatal HIV-1 transmission according to maternal immunologic, virologic, and placental factorsJAMA, 1993
- High risk of HIV-1 infection for first-born twinsThe Lancet, 1991